Butein inhibits NF-κB activation and reduces infiltration of inflammatory cells and apoptosis after spinal cord injury in rats

Neuroscience Letters

Volumn 542, Issue , 2013, Pages 87-91

  Lu, Ming ^a   Wang, Shouyu ^a   Han, Xin ^a   Lv, Decheng ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Butein; IKK inhibitors; Inflammatory response; Neuroprotection; NF B; Spinal cord injury

Indexed keywords

BUTEIN; CASPASE 3; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; IN VIVO STUDY; INFLAMMATORY CELL; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY;

ANIMALS; APOPTOSIS; CASPASE 3; CHALCONES; ENZYME ACTIVATION; FEMALE; I-KAPPA B PROTEINS; INFLAMMATION; NEUROPROTECTIVE AGENTS; NEUTROPHIL INFILTRATION; NF-KAPPA B; PEROXIDASE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES; TRANSCRIPTION FACTOR RELA;

EID: 84876727874     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.03.004     Document Type: Article

References (43)

1. Bao F., Liu D. Peroxynitrite generated in the rat spinal cord induces apoptotic cell death and activates caspase-3. Neuroscience 2003, 116:59-70.
2. Bao F., Liu D. Hydroxyl radicals generated in the rat spinal cord at the level produced by impact injury induce cell death by necrosis and apoptosis: protection by a metalloporphyrin. Neuroscience 2004, 126:285-295.
3. Beattie M.S. Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol. Med. 2004, 10:580-583.
4. Beck K.D., Nguyen H.X., Galvan M.D., Salazar D.L., Woodruff T.M., Anderson A.J. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433-447.
5. Bethea J.R. Spinal cord injury-induced inflammation: a dual-edged sword. Prog. Brain Res. 2000, 128:33-42.
6. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappa B activation. J. Neurosci. 1998, 18:3251-3260.
7. Brambilla R., Bracchi-Ricard V., Hu W.H., Frydel B., Bramwell A., Karmally S., Green E.J., Bethea J.R. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 2005, 202:145-156.
8. Byrnes K.R., Stoica B.A., Fricke S., Di Giovanni S., Faden A.I. Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain 2007, 130:2977-2992.
9. Chatzipanteli K., Yanagawa Y., Marcillo A.E., Kraydieh S., Yezierski R.P., Dietrich W.D. Posttraumatic hypothermia reduces polymorphonuclear leukocyte accumulation following spinal cord injury in rats. J. Neurotrauma 2000, 17:321-332.
10. Chua A.W., Hay H.S., Rajendran P., Shanmugam M.K., Li F., Bist P., Koay E.S., Lim L.H., Kumar A.P., Sethi G. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-kappa B activation in breast and pancreatic tumor cells. Biochem. Pharmacol. 2010, 80:1553-1562.
11. Cho N., Choi J.H., Yang H., Jeong E.J., Lee K.Y., Kim Y.C., Sung S.H. Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines. Food Chem. Toxicol. 2012, 50:1940-1945.
12. Conti A., Cardali S., Genovese T., Di Paola R., La Rosa G. Role of inflammation in the secondary injury following experimental spinal cord trauma. J. Neurosurg. Sci. 2003, 47:89-94.
13. Dumont R.J., Okonkwo D.O., Verma S., Hurlbert R.J., Boulos P.T., Ellegala D.B., Dumont A.S. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin. Neuropharmacol. 2001, 24:254-264.
14. Dumont R.J., Okonkwo D.O., Verma S., Hurlbert R.J., Boulos P.T., Ellegala D.B., Dumont A.S. Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin. Neuropharmacol. 2001, 24:265-279.
15. Fehlings M.G., Baptiste D.C. Current status of clinical trials for acute spinal cord injury. Injury 2005, 36(Suppl. 2):B113-B122.
16. Grossman S.D., Rosenberg L.J., Wrathall J.R. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp. Neurol. 2001, 168:273-282.
17. Hagg T., Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J. Neurotrauma 2006, 23:264-280.
18. Hall E.D., Springer J.E. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004, 1:80-100.
19. Han X., Lu M., Wang S., Lv D.C. Targeting IKK/NF-kappaB pathway reduces infiltration of inflammatory cells and apoptosis after spinal cord injury in rats. Neurosci. Lett. 2012, 511:28-32.
20. Han X., Wang S.Y., Zhang Z., Lü D.C., Liu H.R. BMS-345541 inhibited nuclear factor kappa B expression and improved locomotor function recovery in rats after acute spinal cord injury. Neural. Regen. Res. 2011, 6:1775-1779.
21. Herrmann O., Baumann B., de Lorenzi R., Muhammad S., Zhang W., Kleesiek J., Malfertheiner M., Kohrmann M., Potrovita I., Maegele I., Beyer C., Burke J.R., Hasan M.T., Bujard H., Wirth T., Pasparakis M., Schwaninger M. IKK mediates ischemia-induced neuronal death. Nat. Med. 2005, 11:1322-1329.
22. Hu X., Nesic-Taylor O., Qiu J., Rea H.C., Fabian R., Rassin D.K., Perez-Polo J.R. Activation of nuclear factor-kappaB signaling pathway by interleukin-1 after hypoxia/ischemia in neonatal rat hippocampus and cortex. J. Neurochem. 2005, 93:26-37.
23. Huxford T., Huang D.B., Malek S., Ghosh G. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappa B inactivation. Cell 1998, 95:759-770.
24. Jiang S.C., Bendjelloul F., BalleriniIolanda P., D'Alimonte I., Nargi E., Jiang C., Huang X.J., Rathbone M.P. Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury. Purinergic Signal. 2007, 3:411-421.
25. Jimenez-Garza O., Camacho J., Ibarra A., Martinez A., Guizar-Sahagun G. Early effects of modulating nuclear factor-kappaB activation on traumatic spinal cord injury in rats. Ann. N.Y. Acad. Sci. 2005, 1053:148-150.
26. Kang D.G., Kim Y.C., Sohn E.J., Lee Y.M., Lee A.S., Yin M.H., Lee H.S. Hypotensive effect of butein via the inhibition of angiotensin converting enzyme. Biol. Pharm. Bull. 2003, 26:1345-1347. September 03.
27. Kang D.G., Kim Y.C., Sohn E.J., Lee Y.M., Lee A.S., Yin M.H., Lee H.S. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol. Pharm. Bull. 2004, 27:366-370.
28. Karin M., Yamamoto Y., Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 2004, 3:17-26.
29. Keane R.W., Kraydieh S., Lotocki G., Bethea J.R., Krajewski S., Reed J.C., Dietrich W.D. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J. Neuropathol. Exp. Neurol. 2001, 60:422-429.
30. Kwon B.K., Tetzlaff W., Grauer J.N., Beiner J., Vaccaro A.R. Pathophysiology and pharmacologic treatment of acute spinal cord injury. J. Spine 2004, 4:451-464.
31. Niederberger E., Geisslinger G. The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy. J. FASEB 2008, 22:3432-3442.
32. Pandey M.K., Sandur S.K., Sung B., Sethi G., Kunnumakkara A.B., Aggarwal B.B. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue. J. Biol. Chem. 2007, 282:17340-17350.
33. Paterniti I., Genovese T., Crisafulli C., Mazzon E., Di Paola R., Galuppo M., Bramanti P., Cuzzocrea S. Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma. Naunyn Schmiedebergs Arch. Pharmacol. 2009, 380:179-192.
34. Paterniti I., Mazzon E., Gil C., Impellizzeri D., Palomo V., Redondo M., Perez D.I., Esposito E., Martinez A., Cuzzocrea S. PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury. PLoS ONE 2011, 6:e15937.
35. Rafati D.S., Geissler K., Johnson K., Unabia G., Hulsebosch C., Nesic-Taylor O., Perez-Polo J.R. Nuclear factor-kappaB decoy amelioration of spinal cord injury-induced inflammation and behavior outcomes. J. Neurosci. Res. 2008, 86:566-580.
36. Rowland J.W., Hawryluk G.W., Kwon B., Fehlings M.G. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg. Focus 2008, 25:E2.
37. Sribnick E.A., Samantaray S., Das A., Smith J., Matzelle D.D., Ray S.K., Banik N.L. Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats. J. Neurosci. Res. 2010, 88:1738-1750.
38. Sribnick E.A., Wingrave J.M., Matzelle D.D., Wilford G.G., Ray S.K., Banik N.L. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J. Neurosci. Res. 2005, 82:283-293.
39. Tator C.H., Fehlings M.G. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 1991, 75:15-26.
40. Tatton W.G., Chalmers-Redman R.M., Ju W.Y., Wadia J., Tatton N.A. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J. Neural Transm. Suppl. 1997, 49:245-268.
41. Trivedi A., Olivas A.D., Noble-Haeusslein L.J., Inflammation Spinal Cord Injury: Infiltrating Leukocytes as Determinants of Injury and Repair Processes. Clin. Neurosci. Res. 2006, 6:283-292.
42. Xu J., Fan G., Chen S., Wu Y., Xu X.M., Hsu C.Y. Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. Brain Res. Mol. Brain Res. 1998, 59:135-142.
43. Yadav V.R., Prasad S., Sung B., Aggarwal B.B. The role of chalcones in suppression of NF-kappaB-mediated inflammation and cancer. Int. Immunopharmacol. 2011, 11:295-309.